10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy
David Scherr, Ana Kanazir, Samik Das, Nikunj Sharda, Jan Martinek, David Nellis et al. 10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy. // Biotechnology and Bioengineering. – 2026. – DOI: 10.1002/bit.70429. – URL: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.70429?af=R
David Scherr, Ana Kanazir, Samik Das, Nikunj Sharda, Jan Martinek, David Nellis, Michael Mollet, & Jon Coffman (2026). 10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70429
David Scherr, et al. “10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy.” Biotechnology and Bioengineering, 2026. doi:10.1002/bit.70429.
@article{Scherr2026,
title = {10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy},
author = {Scherr, David and Kanazir, Ana and Das, Samik and Sharda, Nikunj and Martinek, Jan and Nellis, David and Mollet, Michael and Coffman, Jon},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70429},
url = {https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.70429?af=R}
}
The growing recognition of base editing as a precise genome-engineering strategy for single‑nucleotide conversions without double‑strand breaks has increased interest in its application to animal agriculture, where many economically...
Sensorineural hearing loss (SNHL) is a prevalent auditory disorder, with noise exposure being its primary etiological factor; however, its molecular mechanisms and therapeutic targets remain poorly understood. This study integrated...
Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.